Skip to content
★ Sign in to follow
PS

Pritesh Shah

Executive
Directeur Commercial
Novocure Ltd
Total declarations
127
Company
1
▲ Purchases (1 ops.)
€301k
▼ Sales (78 ops.)
€23.3M

Latest filing published 08 Nov 2023 for Novocure Ltd, €4,507.

Filing timeline

BuySale
Pritesh Shah

Insider track record

Disclosed buys
1
Disclosed sells
78
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 03 Sept 2020 · 2257 days ago · €301k
    +73.3%
    Entry US$80.00 · Close at T+365 US$138.60

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Pritesh Shah: trading record in brief

Pritesh Shah, listed as senior executive, appears in our data through filings on Novocure Ltd shares, published by SEC (Form 4). The record holds 127 filings, for trades running from 6 July 2018 to 7 November 2023.

The open-market side counts 1 purchase for €301k alongside 78 sales for €23.3M. The net balance comes to €23.0M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 14 share grants and 33 option exercises. Since January 2023: no purchases and 8 sales on the market.

The latest filing, published on 8 November 2023, reports an open-market sale of €4,507 in Novocure Ltd. The last purchase on record was published on 3 September 2020, which is 2,257 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Pritesh Shah

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations125 total
  • ▼
    Chief Growth OfficerExecutivesNovocure Ltd
    4,832 USD11SEC
    382 shares@ US$12.650.1% of flowOrdinary SharesSEC:0001562180-23-007594:0
  • ▼
    Chief Growth OfficerExecutivesNovocure Ltd
    5,956 USD26SEC
    273 shares@ US$21.81720.1% of flowOrdinary SharesSEC:0001562180-23-006680:0
  • ◆
    Chief Growth OfficerExecutivesNovocure Ltd
    12,948 USD11SEC
    367 shares@ US$35.280.2% of flowOrdinary SharesSEC:0001562180-23-005760:0
  • ▼
    Chief Growth OfficerExecutivesNovocure Ltd
    224,063 USD29SEC
    2,942 shares@ US$76.160.7% of flowOrdinary SharesSEC:0001562180-23-002580:1
  • ▼
    Chief Growth OfficerExecutivesNovocure Ltd
    1M USD29SEC
    16,909 shares@ US$76.163.9% of flowOrdinary SharesSEC:0001562180-23-002580:2
  • ▼
    Chief Growth OfficerExecutivesNovocure Ltd
    119,570 USD29SEC
    1,570 shares@ US$76.15941.8% of flowOrdinary SharesSEC:0001562180-23-002580:0
  • ◆
    Chief Growth OfficerExecutivesNovocure Ltd
    0SEC
    3,936 shares0Ordinary SharesSEC:0001562180-23-002492:1
  • ◆
    Chief Growth OfficerExecutivesNovocure Ltd
    0SEC
    43,246 shares0Ordinary SharesSEC:0001562180-23-002492:2
  • ▼
    Chief Growth OfficerExecutivesNovocure Ltd
    70,535 USD29SEC
    937 shares@ US$75.27791.0% of flowOrdinary SharesSEC:0001562180-23-002492:0
  • ▼
    Chief Growth OfficerExecutivesNovocure Ltd
    146,840 USD29SEC
    1,923 shares@ US$76.360.4% of flowOrdinary SharesSEC:0001645113-23-000030:1
  • ◆
    Chief Growth OfficerExecutivesNovocure Ltd
    0SEC
    19,055 shares0Ordinary SharesSEC:0001645113-23-000030:0
  • ▼
    Chief Commercial OfficerExecutivesNovocure Ltd
    41,796 USD26SEC
    387 shares@ US$108.000.6% of flowOrdinary SharesSEC:0001645113-23-000008:0
  • ▼
    Chief Commercial OfficerExecutivesNovocure Ltd
    21,261 USD29SEC
    269 shares@ US$79.0370.3% of flowOrdinary SharesSEC:0001645113-22-000075:0
  • ◆
    Chief Commercial OfficerExecutivesNovocure Ltd
    18,431 USD11SEC
    312 shares@ US$59.0750.3% of flowOrdinary SharesSEC:0001645113-22-000059:0
  • ▼
    Chief Commercial OfficerExecutivesNovocure Ltd
    261,196 USD29SEC
    3,669 shares@ US$71.190.8% of flowOrdinary SharesSEC:0001645113-22-000031:1
  • ◇
    Chief Commercial OfficerExecutivesNovocure Ltd
    572,455 USD12SEC
    3,717 shares@ US$154.017.6% of flowOrdinary SharesSEC:0001645113-22-000031:0
  • ▼
    Chief Commercial OfficerExecutivesNovocure Ltd
    173,918 USD29SEC
    2,481 shares@ US$70.100.5% of flowOrdinary SharesSEC:0001645113-22-000030:1
  • ▼
    Chief Commercial OfficerExecutivesNovocure Ltd
    368,198 USD30SEC
    5,294 shares@ US$69.555.3% of flowOrdinary SharesSEC:0001645113-22-000030:0
  • ▼
    Chief Commercial OfficerExecutivesNovocure Ltd
    74,277 USD29SEC
    997 shares@ US$74.500.2% of flowOrdinary SharesSEC:0001645113-22-000020:1
  • ▼
    Chief Commercial OfficerExecutivesNovocure Ltd
    193,031 USD29SEC
    2,632 shares@ US$73.340.6% of flowOrdinary SharesSEC:0001645113-22-000020:2
  • ▼
    Chief Commercial OfficerExecutivesNovocure Ltd
    134,765 USD29SEC
    1,914 shares@ US$70.410.4% of flowOrdinary SharesSEC:0001645113-22-000020:3
  • ◆
    Chief Commercial OfficerExecutivesNovocure Ltd
    0SEC
    21,714 shares0Ordinary SharesSEC:0001645113-22-000020:0
  • ▼
    Chief Commercial OfficerExecutivesNovocure Ltd
    44,385 USD29SEC
    321 shares@ US$138.270.1% of flowOrdinary SharesSEC:0001645113-21-000106:1
  • ▼
    Chief Commercial OfficerExecutivesNovocure Ltd
    20,886 USD29SEC
    150 shares@ US$139.240.1% of flowOrdinary SharesSEC:0001645113-21-000106:2
  • ▼
    Chief Commercial OfficerExecutivesNovocure Ltd
    4,205 USD29SEC
    30 shares@ US$140.180.0% of flowOrdinary SharesSEC:0001645113-21-000106:3

25 of 125 declarations